Insider tradingForm 4
Nurix Therapeutics, Inc. (NRIX) Insider Trading
5 open-market trades reported since Sep 1, 2026: 0 purchases worth $0 and 5 sales worth $885K.
By insider
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Gwenn Hansen | Chief Scientific Officer | 0 | $0 | 2 | $73K |
| Julia P. Gregory | Director | 0 | $0 | 1 | $529K |
| Christine Ring | General Counsel | 0 | $0 | 2 | $283K |
All trades
| Filed | Insider | Type | Value | 3 mo. after |
|---|---|---|---|---|
| Oct 15 | Gwenn HansenChief Scientific Officer | ▼ SELL10b5-1 | $36K | |
| Oct 14 | Julia P. GregoryDirector | ▼ SELL | $529K | |
| Oct 2 | Christine RingGeneral Counsel | ▼ SELL10b5-1 | $134K | |
| Sep 2 | Christine RingGeneral Counsel | ▼ SELL10b5-1 | $149K | |
| Sep 1 | Gwenn HansenChief Scientific Officer | ▼ SELL10b5-1 | $37K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings